Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
13.81
-0.03 (-0.22%)
At close: Jan 9, 2026, 4:00 PM EST
13.82
+0.01 (0.07%)
After-hours: Jan 9, 2026, 7:58 PM EST
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $985.46 million as of January 9, 2026. Its market cap has increased by 522.17% in one year.
Market Cap
985.46M
Enterprise Value
802.85M
1-Year Change
522.17%
Ranking
Category
Stock Price
$13.81
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has increased from $782.89M to $985.46M, an increase of 25.88%. That is a compound annual growth rate of 5.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 987.60M | 53.27% |
| Dec 31, 2025 | 644.37M | 316.11% |
| Dec 31, 2024 | 154.86M | 6.21% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
| Oct 21, 2021 | 782.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 979.40B |
| Johnson & Johnson | 496.66B |
| AbbVie | 396.74B |
| UnitedHealth Group | 313.50B |
| AstraZeneca | 297.23B |
| Merck & Co. | 273.88B |
| Novartis AG | 273.11B |
| Novo Nordisk | 254.60B |